Navigation Links
Important funding for nanomedicine research to improve diagnosis and treatment
Date:3/16/2011

This release is available in French.

Toronto (March 16, 2011) Seven new research projects on regenerative medicine and nanomedicine received $16 million in funding. The studies, co-funded by the Canadian Institutes of Health Research (CIHR) and the Canadian Space Agency (CSA), were announced today at the University of Toronto by Dr. Colin Carrie, Member of Parliament for Oshawa; Dr. Jane Aubin, Scientific Director of the Canadian Institutes of Health Research Institute of Musculoskeletal Health and Arthritis; Mr. Gilles Leclerc, Director General, Space Exploration at the Canadian Space Agency; and Professor Peter Lewis, Associate Vice President (Research) at the University of Toronto. "The Government of Canada is proud to support regenerative medicine and nanomedicine projects that will translate into improved health for Canadians," said Dr. Carrie. "The knowledge that emerges from these research projects could also have wide ranging social and economic benefits."

"CIHR is delighted to partner with the Canadian Space Agency to support research aimed at developing technologies and approaches to improve patient outcome," said Dr. Aubin. "The research projects announced today seek to offer new therapies and approaches to treat illnesses and diseases, and ultimately offer better quality of life for patients and their families."

Research on nanomedicine and regenerative medicine is designed to prevent disease and improve human health. Nanomedicine delivers medical technologies that detect or function at the molecular level to diagnose and treat disease, while regenerative medicine stimulates the renewal of bodily tissues and organs or restores function through natural and bioengineered means. Various innovations in these areas have helped combat vascular diseases, cancer, diabetes, multiple sclerosis and other chronic diseases. By promoting research in these areas, CIHR and CSA will be moving Canada to the forefront of modern medical research.

"By working together, CIHR and the CSA are supporting scientific research and innovations that have applications for health care on earth and in space and provide real benefits for Canadians," said Mr. Leclerc. "Our hope is that cutting-edge diagnostic tools will improve astronaut health in space and be adapted for the early detection and treatment of disease here on earth."

"We congratulate the talented researchers who are leading the projects and believe their work on integrating new technologies into health research holds the potential to dramatically change the way we diagnose and treat diseases," said Professor Lewis.

The projects underwent a rigorous and competitive peer review process and were selected according to international standards of scientific excellence.

This funding will enable researchers to potentially:

  • Identify microlesions in multiple sclerosis, using a new tool for quantifying the cause of the disease and how well a treatment is working, Dr. Daniel Ct, Universit Laval;
  • Create personalized nanomedicines that silence cancer-causing genes, Dr. Petier Cullis, University of British Columbia;
  • Develop microchip-based devices to analyze prostate cancer markers in blood, Dr. Shana Kelley, University of Toronto;
  • Generate transplantable, insulin-producing cells from stem cells for diabetes, Dr. Timothy Kieffer, University of British Columbia;
  • Develop innovative sensorimotor rehabilitation approaches for patients with spinal cord injuries or stroke, Dr. Serge Rossignol, Universit de Montral;
  • Study how novel therapeutic interventions can regenerate blood vessels, Dr. Michael Sefton, University of Toronto; and,
  • Develop nanotechnology-enabled image-guided methods of diagnosing and treating lung cancer and vascular diseases, Dr. Gang Zheng, University Health Network.


'/>"/>

Contact: Media Relations
mediarelations@cihr-irsc.gc.ca
Canadian Institutes of Health Research
Source:Eurekalert

Related medicine news :

1. Parents important for keeping adolescents off alcohol
2. Neuroscientists find overlooked brain area is an important locus of depression
3. Researchers find reduced levels of an important neurotransmitter in MS
4. Coma and general anesthesia demonstrate important similarities
5. Researchers discover important link between adrenal gland hormone and brain in hypertension
6. Increased attention to womens health research has yielded gains on some important conditions, but progress lags on others
7. Workers rate safety most important workplace issue in new Labor Day study
8. Street outreach workers an important tool for violence prevention and intervention
9. SIRT1 gene important for memory
10. Healthy Serotonin Levels Shown to Positively Affect many Important Functions of the Mind and Body.
11. Free Clinics Play Important Role for Uninsured in U.S.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... Overland Park, KS (PRWEB) , ... June 27, 2016 , ... ... leader in retailers of Eyeglasses . , Millions of individuals in the United ... life, eyeglasses have become a way to both correct vision and make a fashion ...
(Date:6/26/2016)... , ... June 26, 2016 , ... PawPaws brand ... new product that was developed to enhance the health of felines. The formula is ... The two main herbs in the PawPaws Cat Kidney Support Supplement Soft ...
(Date:6/25/2016)... ... , ... Austin residents seeking Mohs surgery services, can now turn to Dr. ... Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to include ... in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... A recent ... that most people are unfamiliar with. The article goes on to state that individuals ... also many of these less common operations such as calf and cheek reduction. The ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
(Date:6/23/2016)... 23, 2016 Roche (SIX: RO, ROG; OTCQX: ... its Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated ... shock. With this clearance, Roche is the first IVD ... solution for sepsis risk assessment and management. ... and PCT levels in blood can aid clinicians in ...
(Date:6/23/2016)... ANGELES , June 23, 2016 ... CAPR ), a biotechnology company focused ... therapeutics, today announced that patient enrollment in its ... in Duchenne) has exceeded 50% of its 24-patient ... enrollment in the third quarter of 2016, and ...
Breaking Medicine Technology: